España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Profound Medical
PROF
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$7.48
0.04
0.54%
At close: -
$7.48
0.00
0.00%
After Hours: Feb 21, 6:12 AM EDT
Get Report
Comment
Q4 2024 Earnings in 11 days from now on Thu Mar 6th, after the market close
Profound Medical (PROF) Forecast
News
Earnings
Profound Medical (PROF) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Profound Medical (NASDAQ:PROF) Stock
Profound Medical Stock (NASDAQ: PROF)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, January 08, 2025
Profound Medical Sees Full Year 2024 Revenue ...
Lekha Gupta
Profound Medical Announced Preliminary Unaudi...
Lekha Gupta
Friday, December 06, 2024
Trading Halt: Halted at 9:10:08 a.m. ET - Tra...
Benzinga Newsdesk
Profound Medical Prices $35M Underwritten Pub...
Benzinga Newsdesk
Thursday, December 05, 2024
Profound Medical Announces Proposed Public Of...
Benzinga Newsdesk
Thursday, November 07, 2024
Profound Medical Q3 2024 GAAP EPS $(0.38) Mis...
Benzinga Newsdesk
Profound Medical Affirms FY2024 Sales Guidanc...
Benzinga Newsdesk
Thursday, August 08, 2024
Profound Reiterates Guidance
Benzinga Newsdesk
Profound Medical Q2 2024 GAAP EPS $(0.28) Bea...
Benzinga Newsdesk
Tuesday, July 16, 2024
Profound Medical shares are trading higher af...
Benzinga Newsdesk
Microsoft To Rally Around 6%? Here Are 10 Top Analyst Forecasts For Tuesday
Avi Kapoor
Stifel Upgrades Profound Medical to Buy, Rais...
Benzinga Newsdesk
Thursday, July 11, 2024
Profound Medical US CMS Has Issued Its Propos...
Benzinga Newsdesk
Thursday, May 09, 2024
Profound Medical Sees FY24 Revenue $11M-$12M ...
Benzinga Newsdesk
Profound Medical Q1 2024 GAAP EPS $(0.26) Bea...
Benzinga Newsdesk
Monday, May 06, 2024
Profound Medical Says Growing Body Of Clinica...
Benzinga Newsdesk
Monday, March 11, 2024
Alliance Global Partners Maintains Buy on Pro...
Benzinga Newsdesk
Friday, March 08, 2024
Stifel Maintains Hold on Profound Medical, Lo...
Benzinga Newsdesk
Thursday, March 07, 2024
Profound Medical: Q4 Earnings Insights
Benzinga Insights
Profound Medical Q4 2023 GAAP EPS $(0.420) Mi...
Benzinga Newsdesk
Earnings Scheduled For March 7, 2024
Benzinga Insights
Tuesday, January 16, 2024
Profound Medical Announces Non-Brokered Priva...
Benzinga Newsdesk
Thursday, January 04, 2024
Alliance Global Partners Maintains Buy on Pro...
Benzinga Newsdesk
Wednesday, January 03, 2024
Profound Medical Announces Preliminary Unaudi...
Benzinga Newsdesk
Thursday, December 28, 2023
Chord Energy, Profound Medical And 3 Stocks To Watch Heading Into Thursday
Avi Kapoor
Profound Medical Prices $20M Public Offering ...
Benzinga Newsdesk
Wednesday, December 27, 2023
Profound Medical Announces Proposed Public Of...
Benzinga Newsdesk
Tuesday, November 28, 2023
Stifel Initiates Coverage On Profound Medical...
Benzinga Newsdesk
Friday, November 03, 2023
Profound Medical Announces CMS Extension Of T...
Benzinga Newsdesk
Thursday, November 02, 2023
Profound Medical Q3 EPS $(0.26) Beats $(0.34)...
Benzinga Newsdesk
Earnings Scheduled For November 2, 2023
Benzinga Insights
Tuesday, September 26, 2023
TD SYNNEX, Profound Medical And 3 Stocks To Watch Heading Into Tuesday
Lisa Levin
Monday, September 25, 2023
Profound Medical Secures FDA 510(k) Clearance...
Benzinga Newsdesk
Thursday, September 07, 2023
Profound Medical Initiates Up To $30M At-The-...
Benzinga Newsdesk
Wednesday, August 09, 2023
Profound Medical Q2 EPS $(0.35) Misses $(0.34...
Benzinga Newsdesk
Earnings Scheduled For August 9, 2023
Benzinga Insights
Friday, August 04, 2023
Benzinga's Top Ratings Upgrades, Downgrades For August 4, 2023
Benzinga Insights
Raymond James Downgrades Profound Medical to ...
Benzinga Newsdesk
Thursday, May 11, 2023
TD Cowen Maintains Outperform on Profound Med...
Benzinga Newsdesk
Alliance Global Partners Maintains Buy on Pro...
Benzinga Newsdesk
Wednesday, May 10, 2023
Profound Medical: Q1 Earnings Insights
Benzinga Insights
Profound Medical Q1 EPS $(0.32) Beats $(0.34) Estimate, Sales $1.86M Miss $2.11M Estimate
Michael Horton
Earnings Scheduled For May 10, 2023
Benzinga Insights
Tuesday, March 21, 2023
Benzinga's Top Ratings Upgrades, Downgrades For March 21, 2023
Benzinga Insights
Jefferies Downgrades Profound Medical to Equa...
Benzinga Newsdesk
Tuesday, March 07, 2023
Profound Medical Q4 EPS $(0.46) Misses $(0.36) Estimate, Sales $1.30M Miss $2.72M Estimate
Happy Mohamed
Earnings Scheduled For March 7, 2023
Benzinga Insights
Monday, March 06, 2023
Earnings Preview For Profound Medical
Benzinga Insights
Friday, November 04, 2022
Raymond James Upgrades Profound Medical to St...
Benzinga Newsdesk
Profound Medical shares are trading higher af...
Michael Horton
Show More
